Skip to content
  • Wednesday, 28 October 2026
  • 1:20 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Discovery of Fam102a Protein as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis Treatment
Stem Cell & Regenerative Medicine

Discovery of Fam102a Protein as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis Treatment

Dwi Wanna May 24, 2026 0

A breakthrough study led by researchers at the Institute of Science Tokyo has identified a critical protein, Fam102a (Family with…

Read More
Stem Cell & Regenerative Medicine

HKUMed Researchers Identify Piezo1 Protein as the Key Exercise Sensor in Bone Maintenance and Potential Target for Osteoporosis Treatment

Dwi Wanna May 19, 2026 0

Researchers from the Department of Medicine at the School of Clinical Medicine, LKS Faculty of Medicine, University of Hong Kong…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a as a Dual Regulator in Bone Remodeling Offers New Pathways for Osteoporosis Treatment

Dwi Wanna May 17, 2026 0

In a significant advancement for regenerative medicine and skeletal health, a team of researchers at the Institute of Science Tokyo…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a Protein as a Novel Bone Remodeling Factor Offers New Pathway for Osteoporosis Treatment

Dwi Wanna May 9, 2026 0

In a landmark study published in the journal Nature Communications on January 2, 2025, a research team led by Professor…

Read More
Stem Cell & Regenerative Medicine

HKUMed Researchers Identify Piezo1 as the Biological Exercise Sensor for Bone Health Paving the Way for Novel Osteoporosis Treatments

Dwi Wanna May 5, 2026 0

Researchers from the Department of Medicine at the School of Clinical Medicine, LKS Faculty of Medicine, University of Hong Kong…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a as a Dual Regulator in Bone Remodeling Offers New Pathways for Osteoporosis Treatment

Dwi Wanna May 1, 2026 0

In a landmark study that could redefine the clinical approach to metabolic bone diseases, a research team led by Professor…

Read More
Stem Cell & Regenerative Medicine

HKUMed Researchers Identify Piezo1 Protein as Bone Exercise Sensor Opening New Frontiers for Osteoporosis Treatment

Dwi Wanna Apr 28, 2026 0

In a landmark study that bridges the gap between physical mechanobiology and molecular pharmacology, researchers from the LKS Faculty of…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis Treatment

Dwi Wanna Apr 23, 2026 0

In a landmark study that promises to redefine the landscape of musculoskeletal medicine, researchers at the Institute of Science Tokyo…

Read More
Stem Cell & Regenerative Medicine

University of Hong Kong Researchers Identify Biological Exercise Sensor to Combat Osteoporosis and Bone Loss in Aging Populations

Dwi Wanna Apr 20, 2026 0

Researchers from the Department of Medicine at the School of Clinical Medicine, LKS Faculty of Medicine, University of Hong Kong…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a as a Dual Regulator of Bone Remodeling Offers New Pathways for Osteoporosis Treatment

Dwi Wanna Apr 16, 2026 0

The intricate balance of the human skeletal system relies on a continuous cycle of renewal known as bone remodeling, a…

Read More

Posts pagination

1 2 3 4
Teva Pharmaceutical Secures FDA Approval for Ponlimsi Biosimilar to Prolia, Advances Xolair Biosimilar Applications in US and EUUC San Diego Researchers Unveil High-Efficiency Piezoelectric Hybrid Power Converters to Address Escalating Energy Demands in Modern Data CentersHow most-favored-nation pricing is reshaping generic drug economics, according to Dr. Reddy’s finance directorArtificial Intelligence Decodes the Molecular Mystery of Supercooled Water Structure
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
The oral exposure challenge in PROTACs: What drug developers need to solve earlyThe Silence Broken: How Brain-Computer Interfaces are Restoring the Human Voice for Those Paralyzed by ALSESMO26: KEYNOTE-C93 Backs Chemo-Free Keytruda in dMMR Endometrial CancerThe Discovery of REM-like Sleep in Jumping Spiders Challenges Traditional Views of Animal Consciousness
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
The oral exposure challenge in PROTACs: What drug developers need to solve early
Lana Keisha Oct 28, 2026
Environmental & Analytical Chemistry
The Silence Broken: How Brain-Computer Interfaces are Restoring the Human Voice for Those Paralyzed by ALS
Abdurrohim Arsyad Oct 28, 2026
Pharmaceutical R&D
ESMO26: KEYNOTE-C93 Backs Chemo-Free Keytruda in dMMR Endometrial Cancer
Teuku Ryan Oct 28, 2026
Molecular & Cell Biology
The Discovery of REM-like Sleep in Jumping Spiders Challenges Traditional Views of Animal Consciousness
Angie Faith Oct 28, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ